Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: Implications for resection margin assessment

Histopathology

Volumn 59, Issue 6, 2011, Pages 1111-1121

  Verbeke, Caroline Sophie ^a   Knapp, Johannes ^b,c   Gladhaug, Ivar Prydz ^d  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Growth pattern; Pancreatic cancer; Pancreatoduodenectomy; Rectal cancer; Resection margin

Indexed keywords

AMPULLARY CANCER; ARTICLE; BILE DUCT CANCER; CANCER CELL; CANCER SURGERY; CANCER SURVIVAL; CELL DENSITY; DISTAL BILE DUCT CANCER; EPITHELIAL MESENCHYMAL TRANSITION; PANCREAS CANCER; PANCREAS HEAD CANCER; PRIORITY JOURNAL; RECTUM CANCER; TUMOR GROWTH;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE PROGRESSION; HUMANS; PANCREATIC NEOPLASMS; RECTAL NEOPLASMS;

EID: 84855931232     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04056.x     Document Type: Article

References (61)

1. Carpelan-Holmström M, Nordling S, Pukkala E et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005; 54; 385-387.
2. Alexakis N, Halloran C, Raraty M et al. Current standards of surgery for pancreatic cancer. Br. J. Surg. 2004; 91; 1410-1427.
3. Matsuno S, Egawa S, Unno M. R0 resection for ductal pancreatic cancer - Japanese experience. Am. J. Surg. 2007; 194; S110-S114.
4. Wagner M, Redaelli C, Lietz M et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br. J. Surg. 2004; 91; 586-594.
5. Neoptolemos JP, Stocken DD, Dunn JA et al. Influence of resection margin on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann. Surg. 2001; 234; 758-768.
6. Yeo CJ, Cameron JL, Sohn TA et al. Six hundred and fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann. Surg. 1997; 226; 248-260.
7. Butturini G, Stocken DD, Wente MN et al. Influence of resection margins and treatment on survival in patients with pancreatic cancer. Meta-analysis of randomized controlled trials. Arch. Surg. 2008; 143; 75-83.
8. Raut CP, Tseng JF, Sun CC et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann. Surg. 2007; 246; 52-60.
9. Pingpank JF, Hoffman JP, Ross EA et al. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J. Gastrointest. Surg. 2001; 5; 121-130.
10. Verbeke CS, Leitch D, Menon KV et al. Redefining the R1 resection in pancreatic cancer. Br. J. Surg. 2006; 93; 1232-1237.
11. Westgaard A, Tafjord S, Farstad IN et al. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer 2008; 8; 5.
12. Esposito I, Kleeff J, Bergmann F et al. Most pancreatic cancer resections are R1 resections. Ann. Surg. Oncol. 2008; 15; 1651-1660.
13. Menon KV, Gomez D, Smith AM et al. Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB 2009; 11; 18-24.
14. Verbeke CS. Resection margins and R1 rates in pancreatic cancer - are we there yet? Histopathology 2008; 52; 787-796.
15. Hruban RH, Bishop Pitman M, Klimstra DS. Tumors of the pancreas. Atlas of tumor pathology, 4th Series, Fascicle 6. Washington, DC: Armed Forces Institute of Pathology, 2007.
16. Khalifa MA. Intraoperative assessment of the Whipple resection specimen. J. Clin. Pathol. 2007; 60; 975-980.
17. Royal College of Pathologists. Standards and datasets for reporting cancers. Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct, 2nd edn. London: Royal College of Pathologists, 2010.
18. Wibe A, Rendedal PR, Svensson E et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br. J. Surg. 2002; 89; 327-334.
19. Birbeck KF, Macklin CP, Tiffin NJ et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann. Surg. 2002; 235; 449-457.
20. Nagtegaal ID, Corrie A, Marijnen M et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Not one millimetre but two millimetres is the limit. Am. J. Surg. Pathol. 2002; 26; 350-357.
21. Sobin LH, Gospodarowicz MK, Wittekind Ch (eds). International Union Against Cancer TNM classification of malignant tumors, 7th edn. New York, NY: Wiley-Blackwell, 2009.
22. Masugi Y, Yamazaki K, Hibi T et al. Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer. Hum. Pathol. 2010; 41; 1061-1068.
23. Bandyopadhyay S, Basturk O, Coban I et al. Isolated solitary ducts (naked ducts) in adipose tissue: a specific but underappreciated finding of pancreatic adenocarcinoma and one of the potential reasons of understaging and high recurrence rate. Am. J. Surg. Pathol. 2009; 33; 425-429.
24. Winter JM, Ting AH, Vilardell F et al. Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clin. Cancer Res. 2008; 14; 412-418.
25. Royal College of Pathologists. Standards and datasets for reporting cancers. Dataset for colorectal cancer, 2nd edn. London: Royal College of Pathologists, 2007.
26. Halvorsen TB, Seim E. Degree of differentiation in colorectal adenocarcinomas: a multivariate analysis of the influence on survival. J. Clin. Pathol. 1988; 41; 532-537.
27. Longnecker D, Kato Y, Konishi Y et al. Comparison of histologic type and stage of exocrine pancreatic neoplasms from surgical series in Europe, Japan and the United States. In Beger HG, Büchler MW, Schoenberg MH eds. Cancer of the pancreas: molecular biology, progress in diagnosis and treatment. Ulm: University of Ulm, 1996; 47-54.
28. Klöppel G, Lingenthal G, von Bülow M, Kern HF. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-pathological correlation in a series of 75 cases. Histopathology 1985; 9; 841-856.
29. Adsay NV, Basturk O, Bonnett M et al. A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma. Am. J. Surg. Pathol. 2005; 29; 724-733.
30. Jass JR, Ajioka Y, Allen JP et al. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 1996; 28; 543-548.
31. Jarufe NP, Coldham C, Mayer AD et al. Favourable prognostic factors in a large UK experience of adenocarcinomas of the head of pancreas and periampullary region. Dig. Surg. 2004; 21; 202-209.
32. Zlobec I, Minoo P, Karamitopoulou E et al. Role of tumor size in the pre-operative management of rectal cancer patients. BMC Gastroenterol. 2010; 10; 61.
33. Prim RC. Shortest connection networks and some generalizations. Bell System Tech. J. 1957; 36; 1389-1401.
34. Graham RL, Hell P. On the history of the minimum spanning tree problem. Ann. History Comput. 1985; 7; 43-57.
35. Choi HK, Bengtsson E, Jarkrans T et al. Minimum spanning trees (MST) as a tool for describing tissue architecture when grading bladder carcinoma. Lecture Notes Comput. Sci. 1995; 974; 615-620.
36. Kolles H, Ludt H, Vince GH et al. Application of minimal spanning trees in glioma grading: a CLIPPER program for the calculation and construction of minimal spanning trees. Comput. Meth. Prog. Biomed. 1994; 42; 201-206.
37. Brinkhuis M, Baak JPA, Meijer GA et al. Value of quantitative pathological variables as prognostic factors in advanced ovarian carcinoma. J. Clin. Pathol. 1996; 49; 142-148.
38. Matos M, Raby BN, Zahm JM et al. Cell migration and proliferation are not discriminatory factors in the in vitro sociologic behavior of bronchial epithelial cell lines. Cell Motil. Cytoskeleton 2002; 53; 53-65.
39. Palmer JE, Sant Cassia LJ, Irwin C et al. Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary. Int. J. Gynecol. Pathol. 2007; 26; 395-403.
40. Palmer JE, Sant Cassia LJ, Irwin CJ et al. The prognostic and predictive value of syntactic structure analysis in serous carcinoma of the ovary. Int. J. Gynecol. Pathol. 2008; 27; 191-198.
41. Campbell F, Smith RA, Whelan P et al. Classification of R1 resection for pancreatic cancer: the prognostic relevance of tumour involvement within 1mm of a resection margin. Histopathology 2009; 55; 277-283.
42. Jamieson NB, Foulis AK, Oien KA et al. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann. Surg. 2010; 251; 1003-1010.
43. Chang DK, Johns AL, Merrett ND et al. Margin clearance and outcome in resected pancreatic cancer. J. Clin. Oncol. 2009; 27; 2855-2862.
44. Kim J, Reber HA, Dry SM et al. Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut 2006; 55; 1598-1605.
45. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 2003; 3; 362-374.
46. Nakamura T, Kuwai T, Kitadai Y et al. Zonal heterogeneity for gene expression in human pancreatic carcinoma. Cancer Res. 2007; 67; 7597-7604.
47. Niedergethmann M, Alves F, Neff JK et al. Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br. J. Cancer 2007; 97; 1432-1440.
48. Hotz B, Arndt M, Dullat S et al. Epithelial to mesenchymal transition: expression of the regulators snail, slug and twist in pancreatic cancer. Clin. Cancer Res. 2007; 13; 4769-4776.
49. Nishioka R, Itoh S, Gui T et al. SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo. Exp. Mol. Pathol. 2010; 89; 149-157.
50. Thompson EW, Newgreen DF. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005; 65; 5991-5995.
51. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006; 66; 8319-8326.
52. Hase K, Shatney C, Johnson D, Trolloe M, Vierra M. Prognostic value of tumour 'budding' in patients with colorectal cancer. Dis. Colon Rectum 1993; 36; 627-635.
53. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002; 40; 127-132.
54. Westgaard A, Schjølberg AR, Cvancarova M et al. Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours. Histopathology 2009; 54; 337-347.
55. Hatzaras I, George N, Muscarella P et al. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann. Surg. Oncol. 2010; 17; 991-997.
56. Woo SM, Ryu JK, Lee SH et al. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann. Surg. Oncol. 2007; 14; 3195-3201.
57. Kamposioras K, Anthoney A, Ferentinos G et al. Distal bile duct cancer - clinicopathological features and prognostic factors. Pancreatology 2010; 10; 361.
58. Sarmiento JM, Nagorney DM, Sarr MG et al. Periampullary cancers: are there differences? Surg. Clin. North Am. 2001; 81; 543-555.
59. Cheng Q, Luo X, Zhang B et al. Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases. Ann. Surg. Oncol. 2006; 14; 1212-1219.
60. Sommerville CA, Limongelli P, Pai M et al. Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma: an analysis of clinicopathological factors. J. Surg. Oncol. 2009; 100; 651-656.
61. Qiao Q, Zhao Y, Ye M et al. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J. Surg. 2007; 31; 137-143.